Welcome To ORINOVE INC.

Solving unmet medical needs with innovative medicine

Orinove Inc., is a pharmaceutical company focused on novel products for the treatment of unmet medical needs and serious diseases.

Trusted by 25,000+ world-class brands and organizations of all sizes

A purple letter is in the middle of the word " blue ".
A black background with the word farm written in it.
A black and white image of the word " mentor ".
14K+

Happy Customer

27K+

Product Sold

20+

Years Experience

About Us

We Are A Pharmaceutical Company

Orinove Inc., is a pharmaceutical company focused on novel products for the treatment of unmet medical needs and serious diseases.

ORIN1001 is the lead proprietary oral drug candidate for the treatment of cancer and IPF (idiopathic pulmonary fibrosis). 

Our Vision

Mi est nunc lacus cursus malesuada luctus enim. Euismod convallis ligula pede feugiat integer sem vehicula cursus.

Our Mission

Mi est nunc lacus cursus malesuada luctus enim. Euismod convallis ligula pede feugiat integer sem vehicula cursus.

Our Motto

Mi est nunc lacus cursus malesuada luctus enim. Euismod convallis ligula pede feugiat integer sem vehicula cursus.

Technology

A pharmacy with world-class service.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

24/7 Support

Porta platea litora orci felis magna maximus euismod nunc semper

20+
Yearsof of Experience
What We offer

A pharmacy with world-class service.

Emergency Care
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Emergency
Check & Screening
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Medical Check
Vaccination
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Vaccination
Surgery Room
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Surgery Room
Blood Test
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Blood Test
Pharmacy Store
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Pharmacy Store
ORIN1001: A new way to treat cancer.

ORIN1001: A promising way to treat pulmonary fibrosis and other serious diseases

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Targeting the IRE1a pathway,

Intrinsic for cell survival during times of extreme stress such as cancer, chemotherapy and fibrosis.

Groundbreaking research demonstrates,

Activation of the IRE1 pathway in cancer and IPF. Thus, blocking this pathway results in reduction in advanced tumors and fibrosis progression.

We are developing ORIN1001,

A small molecule inhibitor of the IRE1 pathway for the treatment of various cancers, including breast cancer, and fibrosis disorders.

A man in white lab coat holding a tablet.
Our Technology

ORIN1001: A new way to treat cancer

Meet Our Leadership Team

Send Us A Note

To contact us about our ongoing clinical trials or investor opportunities, please contact us below.  

Scroll to Top